Madrigal Pharmaceuticals (YDO1) Revenue

1 Followers

Madrigal Pharmaceuticals Revenue

Madrigal Pharmaceuticals had a revenue of 364.25M in the quarter ending Jun 30, 2026, with 17.00%. This bring the company's revenue in the last twelve months to 1.28B, Decreased 13.37%. In the fiscal year ending Dec 31, 2025, Madrigal Pharmaceuticals had annual revenue of 958.40M with 432.05% growth.

Revenue (ttm)

1.28B

Revenue Growth

133.47%

P/S Ratio

11.29

Revenue/Employee

€1,047,435

Employees

915

Market Cap

€10.82B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	958.40M	778.27M	+432.05%
Dec 31, 2024	180.13M	―	+∞%
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―